Sample | SGD | ACE activity (%) |
---|
Untreated control | – | 100 ± 5.23a |
Captopril | – | 73.99 ± 5.23b |
FDVA | no | 16.36 ± 5.52c |
yes | 17.57 ± 5.52c |
DVA | no | 41.55 ± 5.52d |
yes | 17.57 ± 5.52c |
- Data presented are means ± standard errors of 12 replicates. Captopril (1 nM) was included as a positive control treatment. Values with different subscripts differ significantly (P < 0.001 for comparisons bc and bd, and for all comparisons with the untreated control; P < 0.01 for comparison cd)